SCHEMBL8099062

SCHEMBL8099062

CC(C)P(=O)(Cl)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2020126 0.78
SCHEMBL661910 0.72
SCHEMBL11415554 0.72
SCHEMBL5944339 0.70
SCHEMBL11418165 0.67
SCHEMBL10629554 0.67
SCHEMBL33722008 0.65 ALDH1A1 (0.35)
SCHEMBL11215176 0.64
SCHEMBL575396 0.64
SCHEMBL6873597 0.64 TRPM8 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720050-A1 PROCESS OF PREPARING HIV CAPSID INHIBITOR GILEAD SCIENCES, INC. (US) 2026-04-08 EP claimed
WO-2024249672-A1 PROCESS OF PREPARING HIV CAPSID INHIBITOR GILEAD SCIENCES, INC. (US) 2024-12-05 WO claimed
CN-109134570-B Preparation method of C4 '-fluorouridine phosphoramidite monomer and C4' -fluorouridine modified RNA 南开大学 2021-08-24 CN claimed
EP-4720050-A1 PROCESS OF PREPARING HIV CAPSID INHIBITOR GILEAD SCIENCES, INC. (US) 2026-04-08 EP disclosed
US-20250213502-A1 Amphetamine Controlled Release, Prodrug, and Abuse-deterrent Dosage Forms Pharmapotheca A, Inc. 2025-07-03 US disclosed
WO-2025098440-A1 DOUBLE-STRANDED SIRNA FOR INHIBITING PNPLA3 EXPRESSION AND CONJUGATE COMPRISING SAME 浙江扬厉医药技术有限公司 2025-05-15 WO disclosed
US-12208068-B2 Amphetamine controlled release, prodrug, and abuse-deterrent dosage forms Pharmapotheca A Inc. (US) 2025-01-28 US disclosed
WO-2024249672-A1 PROCESS OF PREPARING HIV CAPSID INHIBITOR GILEAD SCIENCES, INC. (US) 2024-12-05 WO disclosed
US-12006275-B2 Process for making levoamphetamine Pharmapotheca A, Inc. (US) 2024-06-11 US disclosed
US-20230321010-A1 Amphetamine Controlled Release, Prodrug, and Abuse-deterrent Dosage Forms CHEMAPOTHECA, LLC (US) 2023-10-12 US disclosed
CN-116867795-A Novel method for producing antibody-immunostimulant conjugate 第一三共株式会社 2023-10-10 CN disclosed
CN-1043896-C Method for synthetizing phosphoroamidate and its mixture from amines in water system by direct phosphorylating UNIV QINGHUA (CN) 1999-06-30 CN disclosed
WO-1998042697-A2 LIQUID THIOXANTHONE PHOTOINITIATORS FIRST CHEMICAL CORPORATION (US) 1998-10-01 WO disclosed
CN-1095722-A The method of amine direct phosphorylated synthesizing amino phosphoric acid salt and composition thereof in aqueous systems UNIV QINGHUA (CN) 1994-11-30 CN disclosed
EP-0015483-B1 PROCESS FOR THE PREPARATION OF PHOSPHINIC AND PHOSPHONIC ACID ANHYDRIDES HOECHST AKTIENGESELLSCHAFT (DE) 1982-04-28 EP disclosed
US-4301280-A Preparation of 3-substituted cephalosporins LILLY INDUSTRIES LIMITED (GB) 1981-11-17 US disclosed
US-4267125-A FROM PHOSPHINYL HALIDE AND CARBOXYLIC ANHYDRIDES HOECHST AKTIENGESELLSCHAFT (DE) 1981-05-12 US disclosed
EP-0019401-A1 Process for preparing enamine derivatives, compounds so produced and process for preparing a 3-hydroxy-cephalosporin Lilly Industries Limited (GB) 1980-11-26 EP disclosed
EP-0015483-A1 Process for the preparation of phosphinic and phosphonic acid anhydrides HOECHST AKTIENGESELLSCHAFT (DE) 1980-09-17 EP disclosed
US-4043991-A Preparation of peptides and cephalosporins SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-08-23 US disclosed